Entry
Name
Hepatocellular carcinoma - Cricetulus griseus (Chinese hamster)
Description
Hepatocellular carcinoma (HCC) is a major type of primary liver cancer and one of the rare human neoplasms etiologically linked to viral factors. It has been shown that, after HBV/HCV infection and alcohol or aflatoxin B1 exposure, genetic and epigenetic changes occur. The recurrent mutated genes were found to be highly enriched in multiple key driver signaling processes, including telomere maintenance, TP53, cell cycle regulation, the Wnt/beta-catenin pathway (CTNNB1 and AXIN1), the phosphatidylinositol-3 kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway. Recent studies using whole-exome sequencing have revealed recurrent mutations in new driver genes involved in the chromatin remodelling (ARID1A and ARID2) and the oxidative stress (NFE2L2) pathways.
Class
Human Diseases; Cancer: specific types
BRITE hierarchy
Pathway map
Ortholog table
Organism
Cricetulus griseus (Chinese hamster) [GN:
cge ]
Gene
100754730 Tgfa; LOW QUALITY PROTEIN: protransforming growth factor alpha isoform X2 [KO:K08774 ]
100762359 Igf2; LOW QUALITY PROTEIN: insulin-like growth factor II isoform X2 [KO:K13769 ]
100769697 Plcg1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X2 [KO:K01116 ] [EC:3.1.4.11 ]
100761269 Shc2; LOW QUALITY PROTEIN: SHC-transforming protein 2 [KO:K17447 ]
100769627 Grb2; growth factor receptor-bound protein 2 isoform X1 [KO:K04364 ]
100689251 Pik3ca; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform isoform X1 [KO:K00922 ] [EC:2.7.1.153 ]
100769225 Pik3cd; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X2 [KO:K00922 ] [EC:2.7.1.153 ]
100689252 Pik3cb; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform isoform X2 [KO:K00922 ] [EC:2.7.1.153 ]
100771181 Pik3r2; phosphatidylinositol 3-kinase regulatory subunit beta isoform X2 [KO:K02649 ]
100750761 Pik3r1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649 ]
100774067 phosphatidylinositol 3-kinase regulatory subunit gamma isoform X1 [KO:K02649 ]
100760426 Bad; bcl2-associated agonist of cell death isoform X2 [KO:K02158 ]
100752928 Rb1; LOW QUALITY PROTEIN: retinoblastoma-associated protein isoform X2 [KO:K06618 ]
100758556 E2f1; LOW QUALITY PROTEIN: transcription factor E2F1 isoform X2 [KO:K17454 ]
103160601 Cdkn1a; cyclin-dependent kinase inhibitor 1 isoform X2 [KO:K06625 ]
103159266 Gadd45a; growth arrest and DNA damage-inducible protein GADD45 alpha isoform X2 [KO:K04402 ]
100759228 Gadd45g; growth arrest and DNA damage-inducible protein GADD45 gamma [KO:K04402 ]
100766127 Gadd45b; growth arrest and DNA damage-inducible protein GADD45 beta [KO:K04402 ]
100756705 Ddb2; LOW QUALITY PROTEIN: DNA damage-binding protein 2 [KO:K10140 ]
100773359 Tgfb1; transforming growth factor beta-1 proprotein isoform X2 [KO:K13375 ]
100774918 Tgfb2; transforming growth factor beta-2 proprotein isoform X1 [KO:K13376 ]
100756831 Tgfb3; transforming growth factor beta-3 proprotein isoform X1 [KO:K13377 ]
100771578 Smad2; mothers against decapentaplegic homolog 2 isoform X1 [KO:K04500 ]
100759220 Smad3; mothers against decapentaplegic homolog 3 isoform X3 [KO:K23605 ]
100770737 Smad4; mothers against decapentaplegic homolog 4 isoform X2 [KO:K04501 ]
100763041 Lrp5; low-density lipoprotein receptor-related protein 5 isoform X2 [KO:K03068 ]
100772150 Lrp6; low-density lipoprotein receptor-related protein 6 isoform X2 [KO:K03068 ]
100770288 Dvl1; segment polarity protein dishevelled homolog DVL-1 isoform X4 [KO:K02353 ]
100762587 Dvl2; segment polarity protein dishevelled homolog DVL-2 isoform X2 [KO:K02353 ]
100773535 Dvl3; segment polarity protein dishevelled homolog DVL-3 isoform X2 [KO:K02353 ]
103160455 Frat1; LOW QUALITY PROTEIN: proto-oncogene FRAT1 isoform X2 [KO:K03069 ]
100764150 LOW QUALITY PROTEIN: proto-oncogene FRAT1-like isoform X2 [KO:K03069 ]
113834828 LOW QUALITY PROTEIN: GSK-3-binding protein FRAT2-like [KO:K03096 ]
100767273 Apc2; adenomatous polyposis coli protein 2 isoform X2 [KO:K02085 ]
100759410 Keap1; kelch-like ECH-associated protein 1 isoform X1 [KO:K10456 ]
100752102 Nfe2l2; nuclear factor erythroid 2-related factor 2 isoform X1 [KO:K05638 ]
100768809 Smarcd3; SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 3 isoform X2 [KO:K11650 ]
100770817 Smarcd2; SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 2 isoform X2 [KO:K11650 ]
100773634 Smarcd1; SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 1 isoform X3 [KO:K11650 ]
100773316 Arid1b; LOW QUALITY PROTEIN: AT-rich interactive domain-containing protein 1B isoform X4 [KO:K11653 ]
100771997 Arid1a; AT-rich interactive domain-containing protein 1A isoform X5 [KO:K11653 ]
100766868 SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 isoform X2 [KO:K11651 ]
100769126 Smarcb1; SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 isoform X3 [KO:K11648 ]
100756329 Smarca4; transcription activator BRG1 isoform X1 [KO:K11647 ] [EC:5.6.2.-]
100770307 probable global transcription activator SNF2L2 isoform X7 [KO:K11647 ] [EC:5.6.2.-]
100754162 Arid2; AT-rich interactive domain-containing protein 2 isoform X3 [KO:K11765 ]
Compound
C01245 D-myo-Inositol 1,4,5-trisphosphate
C05981 Phosphatidylinositol-3,4,5-trisphosphate
Reference
Authors
Whittaker S, Marais R, Zhu AX
Title
The role of signaling pathways in the development and treatment of hepatocellular carcinoma.
Journal
Reference
Authors
Zucman-Rossi J, Villanueva A, Nault JC, Llovet JM
Title
Genetic Landscape and Biomarkers of Hepatocellular Carcinoma.
Journal
Reference
Authors
Villanueva A, Newell P, Chiang DY, Friedman SL, Llovet JM.
Title
Genomics and signaling pathways in hepatocellular carcinoma.
Journal
Reference
Authors
Breuhahn K, Longerich T, Schirmacher P
Title
Dysregulation of growth factor signaling in human hepatocellular carcinoma.
Journal
Reference
Authors
Minguez B, Tovar V, Chiang D, Villanueva A, Llovet JM
Title
Pathogenesis of hepatocellular carcinoma and molecular therapies.
Journal
Reference
Authors
Kudo M
Title
Signaling pathway and molecular-targeted therapy for hepatocellular carcinoma.
Journal
Reference
Authors
Nault JC, Zucman-Rossi J
Title
Genetics of hepatocellular carcinoma: the next generation.
Journal
Reference
Authors
Rocken C, Carl-McGrath S.
Title
Pathology and pathogenesis of hepatocellular carcinoma.
Journal
Reference
Authors
Cornella H, Alsinet C, Villanueva A
Title
Molecular pathogenesis of hepatocellular carcinoma.
Journal
Reference
Authors
Niu ZS, Niu XJ, Wang WH
Title
Genetic alterations in hepatocellular carcinoma: An update.
Journal
Reference
Authors
Tannapfel A, Wittekind C
Title
Genes involved in hepatocellular carcinoma: deregulation in cell cycling and apoptosis.
Journal
Reference
Authors
Shiraha H, Yamamoto K, Namba M
Title
Human hepatocyte carcinogenesis (review).
Journal
Reference
Authors
Nault JC, Mallet M, Pilati C, Calderaro J, Bioulac-Sage P, Laurent C, Laurent A, Cherqui D, Balabaud C, Zucman-Rossi J
Title
High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions.
Journal
Reference
Authors
Guichard C, Amaddeo G, Imbeaud S, Ladeiro Y, Pelletier L, Maad IB, Calderaro J, Bioulac-Sage P, Letexier M, Degos F, Clement B, Balabaud C, Chevet E, Laurent A, Couchy G, Letouze E, Calvo F, Zucman-Rossi J
Title
Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma.
Journal
Reference
Authors
Praslicka BJ, Kerins MJ, Ooi A
Title
The complex role of NRF2 in cancer: a genomic view
Journal
Reference
Authors
Kansanen E, Kuosmanen SM, Leinonen H, Levonen AL
Title
The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer.
Journal
Reference
Authors
Taguchi K, Motohashi H, Yamamoto M
Title
Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution.
Journal
Reference
Authors
Klaunig JE, Kamendulis LM, Hocevar BA
Title
Oxidative stress and oxidative damage in carcinogenesis.
Journal
Reference
Authors
Krupp G, Bonatz G, Parwaresch R
Title
Telomerase, immortality and cancer.
Journal
Reference
Authors
Jafri MA, Ansari SA, Alqahtani MH, Shay JW
Title
Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies.
Journal
Reference
Authors
Shay JW
Title
Role of Telomeres and Telomerase in Aging and Cancer.
Journal
Reference
Authors
Granito A, Guidetti E, Gramantieri L
Title
c-MET receptor tyrosine kinase as a molecular target in advanced hepatocellular carcinoma.
Journal
Reference
Authors
Vita M, Henriksson M
Title
The Myc oncoprotein as a therapeutic target for human cancer.
Journal
Reference
Authors
Qu A, Jiang C, Cai Y, Kim JH, Tanaka N, Ward JM, Shah YM, Gonzalez FJ
Title
Role of Myc in hepatocellular proliferation and hepatocarcinogenesis.
Journal
Related pathway
cge04932 Non-alcoholic fatty liver disease
KO pathway
LinkDB
All DBs